UK markets closed

Atai Life Sciences N.V. (ATAI)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.8500-0.0600 (-3.14%)
At close: 04:00PM EDT
1.8000 -0.05 (-2.70%)
After hours: 07:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 307.15M
Enterprise value 147.03M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)935.80
Price/book (mrq)1.26
Enterprise value/revenue 468.26
Enterprise value/EBITDA -4.05

Trading information

Stock price history

Beta (5Y monthly) 0.98
52-week change 3-6.09%
S&P500 52-week change 320.07%
52-week high 32.8500
52-week low 31.0250
50-day moving average 31.9662
200-day moving average 31.6396

Share statistics

Avg vol (3-month) 31.62M
Avg vol (10-day) 31.47M
Shares outstanding 5166.03M
Implied shares outstanding 6166.03M
Float 8126.68M
% held by insiders 19.99%
% held by institutions 128.03%
Shares short (28 Mar 2024) 45.55M
Short ratio (28 Mar 2024) 43.38
Short % of float (28 Mar 2024) 44.37%
Short % of shares outstanding (28 Mar 2024) 43.34%
Shares short (prior month 29 Feb 2024) 43.53M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-186,483.33%

Management effectiveness

Return on assets (ttm)-25.52%
Return on equity (ttm)-17.21%

Income statement

Revenue (ttm)314k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-52.60%
Gross profit (ttm)N/A
EBITDA -121.95M
Net income avi to common (ttm)-40.22M
Diluted EPS (ttm)-0.2500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)179.26M
Total cash per share (mrq)1.08
Total debt (mrq)21.54M
Total debt/equity (mrq)8.82%
Current ratio (mrq)9.22
Book value per share (mrq)1.46

Cash flow statement

Operating cash flow (ttm)-84.12M
Levered free cash flow (ttm)-37.17M